For more Insights on the Lung Cancer Therapeutics Market - Download a Free Sample Report!
The market is concentrated, and the degree of concentration will accelerate during the forecast period. Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. are some of the major market participants. The heavy contribution of the immunomodulatory, strong prevalence of lung cancer, and the increasing number of patient assistance programs will offer immense growth opportunities. However, the adherence to available alternatives will hamper the market growth.
Lung Cancer Therapeutics Market 2021-2025: Segmentation
- Type
- Geography
- North America
- Europe
- Asia
- ROW
Lung Cancer Therapeutics Market 2021-2025: Vendor Analysis and Scope
To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The report also covers the following areas:
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
Lung Cancer Therapeutics Market 2021-2025: Key Highlights
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will assist lung cancer therapeutics market growth during the next five years
- Estimation of the lung cancer therapeutics market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the lung cancer therapeutics market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of lung cancer therapeutics market vendors
Related Reports:
Gout Therapeutics Market -The gout therapeutics market has the potential to grow by USD 2.69 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 14.48%. Download a free sample report now!
Cardiovascular Therapeutics Market -The cardiovascular therapeutics market has the potential to grow by USD 32.06 billion during 2021-2025, and the market's growth momentum will decelerate at a CAGR of 7.18%. Download a free sample report now!
Lung Cancer Therapeutics Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.47% |
Market growth 2021-2025 |
USD 6.79 billion |
Market structure |
Concentrated |
YoY growth (%) |
6.01 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 48% |
Key consumer countries |
US, UK, Canada, China, and France |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download a free sample now to uncover highlights deployed by Companies of lung cancer therapeutics market.
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact:
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article